LD
BSX icon

Lipe & Dalton’s Boston Scientific BSX Stock Holding History

Lipe & Dalton’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$482K Buy
+11,300
New +$614K 0.22% 58

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return

Lipe & Dalton's BSX Position: Q2 2026 in Review

Lipe & Dalton opened a new position in Boston Scientific (BSX) in Q2 2026: 11,300 shares worth $482K. The stake represents 0.22% of the portfolio and ranks #58 among its holdings.

338 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Lipe & Dalton held 11,300 shares of Boston Scientific worth $482K as of Q2 2026.
  • Boston Scientific was a new Lipe & Dalton position in Q2 2026.
  • Boston Scientific made up 0.22% of Lipe & Dalton's portfolio in Q2 2026, its #58 holding.
  • 338 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Lipe & Dalton's 13F filing for Q2 2026, filed 14 Jul 2026.